Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 19/01/2010
PIL Dexamethasone 4mg/ml Injection and Dexamethasone 8mg/2ml Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/01/2010 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/01/2010 and displayed until 19/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/09/2008 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/07/2006 and displayed until 10/09/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 16/08/2005 and displayed until 26/07/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/08/2005 and displayed until 16/08/2005
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
  • Change from BAN to rINN
Updated on 25/03/2003 and displayed until 16/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 05/04/2002 and displayed until 25/03/2003
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
   dexamethasone sodium phosphate